PLX READ THE FULL PLX RESEARCH REPORT Third Quarter 2024 Financial and Operational Review Protalix Biotherapeutics, Inc.
WASHINGTON -- Patients with IgG4-related disease appeared to benefit from inebilizumab (Uplizna), currently approved for ...
Amgen (NASDAQ:AMGN) today announced the presentation of new data across its rare disease portfolio and pipeline at the annual ...
Like a fire alarm sending signals to evacuate a smoky building, the immune system has internal guards to help the body sense ...
Gout causes sudden flares of joint pain, which often arise during the nighttime, and in the big toe, though it may affect other joints including the ankles | Genetics And Genomics ...
Excess sugar links to many health risks. Learn how to cut back and replenish energy levels, prevent chronic diseases, and improve overall health.
While gout is commonly linked to excessive drinking or poor diet, new research has revealed that genetics may play a larger ...
WALTHAM, Mass., Nov. 07, 2024 (GLOBE NEWSWIRE) -- Sobi North America, the North American affiliate of Swedish Orphan Biovitrum AB (Sobi ® ), today announced the presentation of four abstracts that ...
The use of SGLT2 inhibitors vs sulfonylurea was associated with a reduced risk for incident gout and MACE among patients with type 2 diabetes with/at risk for gout.
Gout has often been seen as a consequence of lifestyle choices, but new research is rewriting this narrative. An ...
"Gout is a chronic disease with a genetic basis and is not the fault of the sufferer – the myth that gout is caused by ...